For individuals who have experienced cancer, monitoring for recurrence or metastasis is a vital part of ongoing care.
While traditional imaging (like CT or MRI) can reveal tumor size and location, it often fails to detect the early biological activity of cancer cells.
This is where RGCC’s advanced circulating tumor cell (CTC) testing and genetic profiling offers a valuable advantage.
Onconomics Plus is an advanced personalized oncology assessment developed by RGCC.
In addition to testing the sensitivity of circulating tumor cells to various natural substances and pharmaceutical agents,
it also includes a range of key biomarkers closely associated with tumor behavior.
These biomarkers provide vital insights for designing personalized support strategies, risk evaluation, and ongoing monitoring.
Cranial Electrotherapy Stimulation (CES) is a non-invasive technique that delivers low-level electrical current through earlobe clips to stimulate the brain.
Originally approved by the U.S. FDA for managing anxiety, insomnia, and depression, CES is now increasingly recognized for its potential benefits in neurocognitive health.
Cerebrolysin is a peptide-based neurotrophic therapy composed of highly purified peptides and amino acids.
Widely researched and used across Europe and parts of Asia, it offers dual benefits of neuroprotection and neural regeneration, making it a promising option in the field of cognitive and neurological health.
Peptides are short chains of amino acids that play a critical role in regulating cellular functions. In the field of regenerative medicine, they have gained increasing attention for their ability to influence repair processes, modulate inflammation, and enhance cell-to-cell communication.
When it comes to neurocognitive health, specific peptides show promising potential in improving brain function and slowing cognitive decline—making them valuable tools in both preventive care and functional optimization.
Chelation therapy is traditionally used to remove heavy metals such as lead, mercury, and arsenic from the body.
However, growing research and clinical observations suggest it may also have potential benefits for neurological and cognitive health,
especially in individuals with heavy metal accumulation or compromised vascular function.
When we think about brain health, we often picture older adults.
But research tells a different story—the foundation for cognitive decline often begins quietly in our 30s, 40s, and 50s.
This means that supporting cognitive health shouldn’t be a reaction to memory loss—it should be a proactive part of your lifestyle, starting today.
For many years, dementia was thought to be an inevitable part of aging.
However, modern research has revealed that up to 40% of dementia cases may actually be preventable — and the key lies in lifestyle.
A growing body of evidence shows that certain everyday habits can protect the brain, enhance memory, and reduce cognitive decline as we age.
In today’s fast-paced world, we often underestimate the impact of stress and poor sleep on brain health. However, these two factors are not just linked to mood or energy levels — they are key contributors to long-term cognitive decline if left unaddressed.
When memory slips, focus wavers, or thoughts feel sluggish, it’s natural to wonder: Is this early dementia?
But in many cases, what you’re experiencing might be something far more common—and reversible—known as brain fog.
At BMS Clinic, we frequently help clients distinguish between temporary brain fog and progressive cognitive decline, because early recognition and intervention can make a significant difference in long-term brain health.